Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
08/31/2000 | WO2000012074A3 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
08/31/2000 | DE10008042A1 Neurokinin-1-Rezeptorantagonisten Neurokinin-1 receptor antagonists |
08/31/2000 | CA2366951A1 Methods and compositions for altering mucus secretion |
08/31/2000 | CA2364653A1 Pde iv inhibiting compounds, compositions and methods of treatment |
08/31/2000 | CA2362928A1 Vaccine for house dust mite allergen using naked plasmid dna |
08/31/2000 | CA2362906A1 Dna encoding snorf25 receptor |
08/31/2000 | CA2362533A1 Gene sequence variations with utility in determining the treatment of disease |
08/30/2000 | EP1031348A2 Interleukin-4 production inhibitors |
08/30/2000 | EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers |
08/30/2000 | EP1030911A1 Human aspartic proteases |
08/30/2000 | EP1030845A1 Heterocyclic compounds having mmp and tnf inhibitory activity |
08/30/2000 | EP1030840A1 Cyclic amine derivatives and their use as drugs |
08/30/2000 | EP1030836A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
08/30/2000 | EP1030835A2 Urea derivatives and their use as integrin inhibitors |
08/30/2000 | EP1030683A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
08/30/2000 | EP1030667A1 Use of mirtazapine for treating sleep apneas |
08/30/2000 | EP1030664A1 Pharmaceutical compositions containing zafirlukast |
08/30/2000 | EP1030662A2 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
08/30/2000 | EP1030661A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA 2? INHIBITORS |
08/30/2000 | EP0836606B1 Condensed thiazole derivatives, having 5-ht receptor affinity |
08/30/2000 | EP0799198B1 Anti-inflammatory compounds |
08/30/2000 | EP0584290B1 Endothelin antagonists |
08/30/2000 | CN1265114A Method for large-scale production of Di (uridine 5'-tetraphosphate) and salts thereof |
08/30/2000 | CN1265102A Benzothia (oxa) diazol derivatives and their use as endothelin-receptor antagonists |
08/30/2000 | CN1264588A Powdered 'Yanhouling' medicine and preparing process thereof |
08/30/2000 | CN1055841C External adhesive plaster for treating infantile pneumonia and prepn. method for same external adhesive plaster |
08/29/2000 | US6111078 Staphylococcus aureus rsbU-1 |
08/29/2000 | US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer |
08/29/2000 | US6110952 Preventing or treating nasal congestion, otitis media and sinusitis without undesired side effects, also asthma, pain, migraine, substance abuse and addiction, gastrointestinal disorder, ulcer, stomach hyperacidity |
08/29/2000 | US6110944 LTA4, hydrolase inhibitors |
08/29/2000 | US6110939 As a substance p antagonists treating tachykinin-mediated disease, asthma, central nervous system disorder |
08/29/2000 | US6110933 Amino acid derivatives and their use as phospholipase A2 inhibitor |
08/24/2000 | WO2000049147A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
08/24/2000 | WO2000049015A1 Pyridine compounds and their pharmaceutical use |
08/24/2000 | WO2000049008A1 Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin s |
08/24/2000 | WO2000049007A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s |
08/24/2000 | WO2000049005A1 Bicyclic compounds and their use as integrin receptor ligands |
08/24/2000 | WO2000048994A1 Thioamide derivatives |
08/24/2000 | WO2000048992A1 Acylated aminoacetonitriles as cysteine protease inhibitors |
08/24/2000 | WO2000048989A1 Mevinolin derivatives |
08/24/2000 | WO2000048988A1 Phenylalaninol derivatives |
08/24/2000 | WO2000048626A2 Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammation associated with pulmonary disease |
08/24/2000 | WO2000048624A2 Utilization of orosomucoid in order to produce a pharmaceutical preparation |
08/24/2000 | WO2000048623A1 Novel amide derivatives as growth hormone secretagogues |
08/24/2000 | WO2000048593A1 Epoxide hydrolase complexes and methods therewith |
08/24/2000 | WO2000048587A1 Combinations of formoterol and fluticasone propionate for asthma |
08/24/2000 | WO2000037470A8 Antihistaminic spiro compounds |
08/24/2000 | WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA |
08/24/2000 | WO2000015797A3 Compositions and methods for the treatment of immune related diseases |
08/24/2000 | WO2000015246A9 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
08/24/2000 | WO2000010536A9 Extended release buccal bioadhesive tablet |
08/24/2000 | DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha |
08/24/2000 | CA2368537A1 Combinations of formoterol and fluticasone propionate for asthma |
08/24/2000 | CA2362970A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
08/24/2000 | CA2362862A1 Bicyclic compounds and their use as integrin receptor ligands |
08/24/2000 | CA2362664A1 Utilization of orosomucoid in order to produce a pharmaceutical preparation |
08/24/2000 | CA2362538A1 Secreted proteins and polynucleotides encoding them |
08/24/2000 | CA2362290A1 Novel amide derivatives as growth hormone secretagogues |
08/23/2000 | EP1029869A1 Endothelin converting enzyme inhibitors |
08/23/2000 | EP1029550A1 Preventives and remedies for diffuse lung diseases |
08/23/2000 | EP1028957A1 Piperidine derivatives and their use as tachykinin antagonists |
08/23/2000 | EP1028946A1 Indazole bioisostere replacement of catechol in therapeutically active compounds |
08/23/2000 | EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents |
08/23/2000 | EP0711289B1 Piperazine compounds used in therapy |
08/23/2000 | CN1264425A Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
08/23/2000 | CN1264383A Salts of optically active sulfoxide derivative |
08/23/2000 | CN1264382A Novel compounds |
08/23/2000 | CN1264381A 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists |
08/23/2000 | CN1264378A Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists |
08/23/2000 | CN1264377A Substituted pyrazoles as P38 kinase inhabitors |
08/23/2000 | CN1264376A 3(5)-Heteroaryl substituted pyrazoles as P38 kinase inhibitors |
08/23/2000 | CN1263945A American pig reproduction and respiratory syndrome (PRRS) virus and its use |
08/23/2000 | CN1263889A Monoclinic system sheet crystal tazhanot |
08/22/2000 | US6107473 Kringle-related clone HTHBZ47 |
08/22/2000 | US6107334 Dietary control of arachidonic acid metabolism |
08/22/2000 | US6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
08/22/2000 | US6107291 Antiinflammatory agent |
08/22/2000 | US6106858 Loading active materials of liposomes by dissolving |
08/22/2000 | CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
08/22/2000 | CA2111002C Non-chlorofluorocarbon aerosol formulations |
08/22/2000 | CA2016627C Proteinase inhibitors, process for the preparation thereof and medicaments containing these |
08/17/2000 | WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
08/17/2000 | WO2000047623A1 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
08/17/2000 | WO2000047620A1 Cytokine-binding domain |
08/17/2000 | WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation |
08/17/2000 | WO2000047611A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor |
08/17/2000 | WO2000047602A1 33 human secreted proteins |
08/17/2000 | WO2000047583A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
08/17/2000 | WO2000047580A2 Phenyl urea and phenyl thiourea derivatives |
08/17/2000 | WO2000047578A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors |
08/17/2000 | WO2000047572A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
08/17/2000 | WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists |
08/17/2000 | WO2000047554A2 INHIBITORS OF FACTOR Xa |
08/17/2000 | WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa |
08/17/2000 | WO2000047215A2 Methods for anti-tumor therapy |
08/17/2000 | WO2000047200A1 Combinations of formoterol and a tiotropium salt |
08/17/2000 | WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
08/17/2000 | WO2000012076A9 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
08/17/2000 | CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
08/17/2000 | CA2362390A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors |